Literature DB >> 19307459

Increased CYP4B1 mRNA is associated with the inhibition of dextran sulfate sodium-induced colitis by caffeic acid in mice.

Zhong Ye1, Zhiping Liu, Abigail Henderson, Kwangwon Lee, Jesse Hostetter, Michael Wannemuehler, Suzanne Hendrich.   

Abstract

Susceptibility to inflammatory bowel diseases depends upon interactions between the genetics of the individual and induction of chronic mucosal inflammation. We hypothesized that administration of dietary phenolics, caffeic acid and rutin, would suppress upregulation of inflammatory markers and intestinal damage in a mouse model of colitis. Colitis was induced in C3H/ HeOuJ mice (8 weeks old, 6 male/6 female per treatment) with 1.25% dextran sulfate sodium (DSS) for 6 d in their drinking water. Rutin (1.0 mmol (524 mg)/kg in diet), caffeic acid (1.0 mmol (179 mg)/kg in diet), and hypoxoside extract (15 mg/d, an anticolitic phenolic control) were fed to the mice for 7 d before and during DSS treatment, as well as without DSS treatment. Body weight loss was prevented by rutin and caffeic acid during DSS treatment. Colon lengths in mice fed caffeic acid and hypoxoside during DSS treatment were similar to DSS-negative control. Food intake was improved and myeloperoxidase (MPO) was decreased with each phenolic treatment in DSS-treated mice compared with DSS treatment alone. Colonic mRNA expression of IL-17 and iNOS were inhibited when IL-4 was increased by each phenolic treatment combined with DSS, whereas CYP4B1 mRNA was increased only by caffeic acid in DSS-treated mice, compared with DSS treatment alone. Colonic and cecal histopathology scores of DSS-treated mice were significantly more severe (P < 0.01) than in mice fed caffeic acid before and during DSS treatment, based on mucosal height, necrosis, edema, erosion, and inflammatory cell infiltration. Although both rutin and caffeic acid suppressed the expression of selected inflammatory markers, only caffeic acid protected against DSS-induced colitis, in association with normalization of CYP4B1 expression. The inhibition of DSS-induced colitic pathology by caffeic acid was mediated by mechanisms in addition to anti-inflammatory effects that deserve further study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19307459      PMCID: PMC3758119          DOI: 10.3181/0901-RM-1

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  54 in total

Review 1.  Epithelial secretory response to inflammation.

Authors:  M J Ciancio; E B Chang
Journal:  Ann N Y Acad Sci       Date:  1992       Impact factor: 5.691

Review 2.  Inflammatory bowel disease (2)

Authors:  D K Podolsky
Journal:  N Engl J Med       Date:  1991-10-03       Impact factor: 91.245

3.  Inhibitory effect of di-catechol rooperol on VCAM-1 and iNOS expression in cytokine-stimulated endothelium.

Authors:  J Bereta; M Bereta; A C Allison; P B Kruger; A Koj
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

Review 4.  Experimental models of inflammatory bowel disease.

Authors:  C O Elson; R B Sartor; G S Tennyson; R H Riddell
Journal:  Gastroenterology       Date:  1995-10       Impact factor: 22.682

5.  An enhanced murine model for studies of Serpulina (Treponema) hyodysenteriae pathogenesis.

Authors:  S K Nibbelink; M J Wannemuehler
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

6.  Effect of rooperol on collagen synthesis and cell growth.

Authors:  E Dietzsch; C F Albrecht; M I Parker
Journal:  IUBMB Life       Date:  1999-09       Impact factor: 3.885

Review 7.  Interleukin-17 family members and inflammation.

Authors:  Jay K Kolls; Anders Lindén
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

8.  Species-specific expression of CYP4B1 in rabbit and human gastrointestinal tissues.

Authors:  R A McKinnon; W M Burgess; F J Gonzalez; R Gasser; M E McManus
Journal:  Pharmacogenetics       Date:  1994-10

9.  Clinicopathologic study of dextran sulfate sodium experimental murine colitis.

Authors:  H S Cooper; S N Murthy; R S Shah; D J Sedergran
Journal:  Lab Invest       Date:  1993-08       Impact factor: 5.662

10.  Cancer in patients with ulcerative colitis.

Authors:  L Mellemkjaer; J H Olsen; M Frisch; C Johansen; G Gridley; J K McLaughlin
Journal:  Int J Cancer       Date:  1995-01-27       Impact factor: 7.396

View more
  17 in total

Review 1.  Pharmacological Effects of Polyphenol Phytochemicals on the Intestinal Inflammation via Targeting TLR4/NF-κB Signaling Pathway.

Authors:  Caiyun Yu; Dong Wang; Zaibin Yang; Tian Wang
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

2.  Induction of bone loss by pathobiont-mediated Nod1 signaling in the oral cavity.

Authors:  Yizu Jiao; Youssef Darzi; Kazuki Tawaratsumida; Julie T Marchesan; Mizuho Hasegawa; Henry Moon; Grace Y Chen; Gabriel Núñez; William V Giannobile; Jeroen Raes; Naohiro Inohara
Journal:  Cell Host Microbe       Date:  2013-05-15       Impact factor: 21.023

3.  Orally administered extract from Prunella vulgaris attenuates spontaneous colitis in mdr1a(-/-) mice.

Authors:  Kelley Mk Haarberg; Meghan J Wymore Brand; Anne-Marie C Overstreet; Catherine C Hauck; Patricia A Murphy; Jesse M Hostetter; Amanda E Ramer-Tait; Michael J Wannemuehler
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

4.  Dextran sulfate sodium inhibits alanine synthesis in Caco-2 cells.

Authors:  Zhong Ye; Darya O Mishchuk; Natasha S Stephens; Carolyn M Slupsky
Journal:  Int J Mol Sci       Date:  2011-04-04       Impact factor: 5.923

5.  The role of Dock2 on macrophage migration and functions during Citrobacter rodentium infection.

Authors:  L Ji; Y Chen; L Xie; Z Liu
Journal:  Clin Exp Immunol       Date:  2021-03-22       Impact factor: 5.732

Review 6.  Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components: A Scientific Review with Clinical Application.

Authors:  Romilly E Hodges; Deanna M Minich
Journal:  J Nutr Metab       Date:  2015-06-16

7.  Integrative approach to analyze biodiversity and anti-inflammatory bioactivity of Wedelia medicinal plants.

Authors:  Wen-Ching Lin; Chih-Chun Wen; Yung-Hsiang Chen; Pei-Wen Hsiao; Jiunn-Wang Liao; Ching-I Peng; Ning-Sun Yang
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

8.  Anti-inflammatory activity of bioaccessible fraction from Eryngium foetidum leaves.

Authors:  Suwitcha Dawilai; Chawanphat Muangnoi; Phawachaya Praengamthanachoti; Siriporn Tuntipopipat
Journal:  Biomed Res Int       Date:  2013-09-17       Impact factor: 3.411

9.  Capparis Spinosa L. promotes anti-inflammatory response in vitro through the control of cytokine gene expression in human peripheral blood mononuclear cells.

Authors:  Mouna Moutia; Khadija El Azhary; Anass Elouaddari; Abdellah Al Jahid; Jamal Jamal Eddine; Fouad Seghrouchni; Norddine Habti; Abdallah Badou
Journal:  BMC Immunol       Date:  2016-08-02       Impact factor: 3.615

Review 10.  Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?

Authors:  Fabiana Andréa Moura; Kívia Queiroz de Andrade; Juliana Célia Farias Dos Santos; Orlando Roberto Pimentel Araújo; Marília Oliveira Fonseca Goulart
Journal:  Redox Biol       Date:  2015-10-23       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.